tm logo
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT
Live/Registered
REGISTERED

on 13 Dec 2022

Last Applicant/ Owned by

20800 Swenson Drive, Suite 300

Waukesha

WI

53186

Serial Number

90454793 filed on 08th Jan 2021

Registration Number

6920628 registered on 13th Dec 2022

in the Principal Register

Correspondent Address

Patrick M Bergin

VON BRIESEN & ROPER, S.C.

411 E. WISCONSIN AVENUE, SUITE 1000

MILWAUKEE, WI 53202

Filing Basis

1. use application currently

Disclaimer

NO DATA

MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT

Providing online non-downloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacoRead More

Classification Information


Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacology and toxicology studies of new and next-generation vectors, cell isolation, engineering, culture, expansion, and transplantation, cell processing, storage, and banking for therapeutic application


First Use Date in General

31st Jan 2014

First Use Date in Commerce

31st Jan 2014

Class [041]
Education and Entertainment Services


Providing online non-downloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacology and toxicology studies of new and next-generation vectors, cell isolation, engineering, culture, expansion, and transplantation, cell processing, storage, and banking for therapeutic application


First Use Date in General

31st Jan 2014

First Use Date in Commerce

31st Jan 2014

Mark Details


Serial Number

No 90454793

Mark Type

No Service Mark

Attorney Docket Number

No 040957.00004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Dec 2022REGISTERED-PRINCIPAL REGISTER
27th Sep 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Sep 2022PUBLISHED FOR OPPOSITION
07th Sep 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23rd Aug 2022APPROVED FOR PUB - PRINCIPAL REGISTER
25th Oct 2021TEAS/EMAIL CORRESPONDENCE ENTERED
25th Oct 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
25th Oct 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
24th Apr 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
24th Apr 2021NON-FINAL ACTION E-MAILED